Compartmental organization and chemical profile of dopaminergic and GABAergic neurons in the substantia nigra of the rat

Journal of Comparative Neurology

Volumn 421, Issue 1, 2000, Pages 107-135

  González Hernández, Tomás ^a   Rodríguez, Manuel ^a  

^a UNIVERSIDAD DE LA LAGUNA   (Spain)

Author keywords

Calcium binding proteins; Cholecystokinin; Coexpression; Midbrain; NOS; Topographical distribution

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; CALBINDIN; CALRETININ; CHOLECYSTOKININ; GLUTAMATE DECARBOXYLASE; NITRIC OXIDE SYNTHASE; PARVALBUMIN; TYROSINE 3 MONOOXYGENASE;

ANIMAL TISSUE; ARTICLE; CELL COMPARTMENTALIZATION; CELL POPULATION; CELL STRUCTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; GABAERGIC SYSTEM; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SUBSTANTIA NIGRA; TOPOGRAPHY;

EID: 0342369445     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9861(20000522)421:1<107::AID-CNE7>3.0.CO;2-F     Document Type: Article

References (134)

1. Albin RL, Young AB, Penney JB. 1989. The functional anatomy of basal ganglia disorders. Trends Neurosci 12:366-375.
2. Alfahel-Kakunda A, Silverman WF. 1997. Calcium-binding proteins in the substantia nigra and ventral tegmental area during development: correlation with dopaminergic compartmentation. Brain Res Dev Brain Res 103:9-20.
3. Apicella P, Legallet E, Nieoullon A, Tronche E. 1995. Quantitative behavioral study of the acute and long-term effects of two-stage bilateral 6 OHDA-induced lesions of the nigrostriatal dopaminergic system in monkeys. Behav Neurosci 109:329-341.
4. Appell PP, Behan M. 1990. Sources of subcortical GABAergic projections to the superior colliculus in the cat. J Comp Neurol 302:143-158.
5. Arbuthnott GW. 1978. Studies on the interactions between the substantia nigra and neostriatum. In: Robers PJ, Woodward GN, Iversen LL, editors. Advances in biochemical psychopharmacology, vol 19. New York: Raven Press, p 235-246.
6. Baimbridge KG, Celio MR, Rogers JH. 1992. Calcium-binding proteins in the nervous system. Trends Neurosci 15:303-308.
7. Beckman JS, Chen J, Crow JP, Ye YZ. 1994. Reactions of nitric oxide, superoxide and peroxynitrite with superoxide dismutase in neurodegeneration. Prog Brain Res 103:371-380.
8. Beckstead RM, Domesick VB, Nauta WJH. 1979. Efferent connections of the substantia nigra and ventral tegmental area in the rat. Brain Res 175:191-217.
9. Blümcke I, Hof PR, Morrison JH, Celio MR. 1990. Distribution of parvalbumin immunoreactivity in the visual cortex of Old World monkeys and humans. J Comp Neurol 301: 417-432.
10. Bredt DS, Snyder SH. 1994. Nitric oxide: a physiologic messenger molecule. Annu Rev Biochem 63:175-95
11. Caille I, Dumartin B, Bloch B. 1996. Ultrastructural localization of d1 dopamine receptor immunoreactivity in rat striatonigral neurons and its relation with dopaminergic innervation. Brain Res 730:17-31.
12. Campbell KJ, Takada M, Hattori T. 1991. Co-localization of tyrosine hydroxylase and glutamate decarboxylase in a subpopulation of single nigrotectal projection neurons. Brain Res 558:239-244.
13. Carr PA, Yamamoto T, Karmy G, Baimbridge KG, Nagy JI. 1989. Analysis of parvalbumin and calbindin D28k-immunoreactive neurons in dorsal root ganglia of rat in relation to their cytochrome oxidase and carbonic anhydrase content. Neuroscience 33:363-371.
14. Cortes R, Ceccatelli S, Schalling M, Hökfelt T. 1990. Differential effects of intracerebrovascular colchicine administration on the expression of mRNAs for neuropeptides and neurotransmitters. Synapse 6:369-391.
15. Coward DM. 1982. Classical and non-classical neuroleptics induce super-sensivility of nigral GABAergic mechanisms in the rat. Psychopharmacology 78:180-184.
16. Crawley JN.1991. Cholecystokinin-dopamine interactions. Trends Pharmacol Sci 12:232-236.
17. Dahlström A, Fuxe K. 1964. Evidence for the existence of monoamine-containing neurons in the central nervous system.I. Demonstration of monoamines in cell bodies of brainstem neurons. Acta Physiol Scand Suppl 232:1-55.
18. Danner H, Pfister C. 1982. 7 types of neurons in the substantia nigra of the rat. Golgi rapid-impregnation study. J Hirnforsch 23:553-556.
19. Datta S, Patterson EH, Siwek DF. 1997. Endogenous and exogenous nitric oxide in the pedunculopontine tegmentum induces sleep. Synapse 27: 69-78.
20. Dawson VL, Dawson TM. 1996. Nitric oxide neurotoxicity. J Chem Neuroanat 10:179-190.
21. Dawson VL, Dawson TM, London ED, Bredt DS, Snyder SH. 1991. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc Natl Acad Sci USA 88:6368-6371.
22. Deniau JM, Chevalier G. 1992. The lamellar organization of the rat substantia nigra pars reticulata: distribution of projection neurons. Neuroscience 46:361-377.
23. Deniau JM, Thierry AM. 1997. Anatomical segregation of information processing in the rat substantia nigra pars reticulata. In: Obeso JA, DeLong MR, Ohye C, Marsden CD, editors. The basal ganglia and new surgical approaches for Parkinson's disease. Philadelphia: Lippincott-Raven p 83-96.
24. Deniau JM, Menetrey A, Charpier S. 1996. The lamellar organization of the rat substantia nigra pars reticulata: segregated patterns of striatal afferents and relationship to the topography of corticostriatal projections. Neuroscience 73:761-781.
25. Erulkar SD, Fine A. 1979. Calcium in the nervous system. Rev Neurosci 4:179-232.
26. Esclapez M, Tillakaratne NJK, Tobin AJ, Houser CR. 1993. Comparative localization of mRNAs encoding two forms of glutamic acid decarboxylase with nonradiactive in situ hybridization methods. J Comp Neurol 331:339-362.
27. Esclapez M, Tillakaratne NJK, Kaufman DL, Tobin AJ, Houser CR. 1994. Comparative localization of two forms of glutamic acid decarboxylase and their mRNAs in rat brain supports the concept of functional differences between the forms. J Neurosci 14:1834-1855.
28. Faber-Zurchratter H, Wolf G. 1994. Ultrastructural distribution of NADPH-diaphorase in cortical synapses. NeuroReport 5:2029-2032.
29. Fallon JH, Loughlin SE. 1982. Monoamine innervation of the forebrain: forebrain collateralization. Brain Res Bull 9:295-307.
30. Fallon JH, Loughlin SE. 1985. Substantia nigra. In: Paxinos G, editor. The rat nervous system, vol 1. Sydney: Academis Press, p 353-374.
31. Fallon JH, Hicks R, Loughlin SE. 1983. The origin of cholecystokinin terminals in the basal forebrain of the rat: evidence from immunofluorescence and retrograde tracing. Neurosci Lett 37:29-35.
32. Feigengbaum-Langer L, Graybiel AM. 1989. Distinct nigrostriatal projection systems innervate striosomes and matrix in the primate striatum. Brain Res 498:344-350.
33. Ficarola AS, Mize RR. 1989. The neurons of he substantia nigra and zona incerta which project to the cat superior colliculus are GABA immuno-reactive: a double-label study using GABA immunocytochemistry and lectin regrograde transport. Neuroscience 29:567-581.
34. Fink JS, Smith GP. 1980. Mesolimbocortical dopamine terminal fields are necessary for normal locomotor and investigatory exploration in rats. Brain Res 199:359-384.
35. Gale K. 1980. Chronic blockade of dopamine receptors by antischizophrenic drugs enhances GABA binding in substantia nigra, Nature (Lond) 283:559-570.
36. Garthwaite J. 1991. Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci 14:60-67.
37. Gartwaite J, Boulton CL. 1995. Nitric oxide signaling in the central nervous system. Annu Rev Physiol 57:683-706.
38. Geloso MC, Vinesi P, Michetti F. 1997. Calretinin-containing neurons in trimethyltin-induced neurodegeneration in the rat hippocampus: an immunocytochemical study. Exp Neurol 146:67-73
39. Geloso MC, Vinesi P, Michetti F. 1998. Neuronal subpopulations of developing rat hippocampus containing different calcium-binding proteins behave distintively in trimethyltin-induced neurodegeneration. Exp Neurol 154:645-653.
40. Gerfen CR. 1984. The neostriatal mosaic: compartmentalization of corticostriatal input and striatonigral output systems. Nature 311:361-364.
41. Gerfen CR. 1985. The neostriatal mosaic. I. Compartmental organization of projections from the striatum to the substantia nigra in the rat. J Comp Neurol 236:454-476.
42. Gerfen CR, Baimbridge KG, Miller J. 1985. The neostriatal mosaic: compartmental distribution of calcium-binding protein and parvalbumin in the basal ganglia of the rat and monkey. Proc Natl Acad Sci USA 82:8780-8784.
43. Gerfen CR, Herkenham M, Tribault J. 1987a. The neostriatal mosaic: II. Patch- and matrix-directed mesostriatal dopaminergic and non-dopaminergic systems. J Neurosci 7:3915-3934.
44. Gerfen CR, Baimbridge KG, Tribault J. 1987b. The neostriatal mosaic: III. Biochemical and development dissociation of path-matrix mesostriatal systems. J Neurosci 7:3935-3944.
45. German DC, Manaye KF. 1993. Midbrain dopaminergic neurons (A8, A9, and A10): Three-dimensional reconstruction in the rat. J Comp Neurol 331:297-309.
46. González-Hernández T, Abdala P, Rodriguez M. 1997. NOS expression in nigral cells after excitotoxic and non-excitotoxic lesion of the pedunculopontine tegmental nucleus. Eur J Neurosci 9:2658-2667.
47. Grace AA, Bunney BS. 1985. Opposing effects of striatonigral feedback pathways on midbrain dopamine cell activity. Brain Res 333:271-284.
48. Grofova I, Rinvik E. 1970. An experimental electron microscopic study on the striatonigral projection in the cat. Exp Brain Res 11:249-262.
49. Grofova I, Deniau JM, Kitai ST. 1982. Morphology of the substantia nigra pars reticulata neurons intracellulary labeled with HRP. J Comp Neurol 208:352-368.
50. Haber SN, Groenewegen HJ. 1989. Interrelationship of the distribution of neuropeptides and tyrosine hydroxylase immunoreactivity in the human substantia nigra. J Comp Neurol 290:53-68.
51. Hantraye P, Brouillet E, R Ferrante, Palfi S, Dolan R, Mattheus RT, Beal MF. 1996. Inhibition of neuronal nitric oxide synthase prevents MTPT-induced parkinsonism in baboons. Nature Med 2:1017-1021.
52. Hedreen JC, DeLong MR. 1991. Organization of striatopallidal and striatonigral projections in the macaque. J Comp Neurol 304:569-595.
53. Heizmann CW.1984. Parvalbumin, an intracellular calcium-binding protein, distribution, properties and possible roles in mammalian cell. Experientia 40:91-921.
54. 2+-binding proteins in human neurodegenerative disorders. Trends Neurosci 15:259-264.
55. Hökfelt T, Skirboll L, Rehfeld JF, Goldstein M, Markey K, Dann O. 1980. A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contains a cholecystokinin-like peptide: evidence from immunocytochemistry combined with retrograde tracing. Neuroscience 5:2093-2124.
56. Hökfelt T, Martensson R, Björklund A, Kleinau S, Goldstein M. 1984. Distribution maps of tyrosine-hydroxylase-immunoreactive neurons in the rat brain. In: Björklund A, Hökfeld T, editors. Handbook of chemical neuroanatomy, vol 4. Amsterdam: Elsevier, p 277-379.
57. Hontanilla B, De las Heras S, Giménez-Amaya JM. 1996. A topographic re-evaluation of the nigrostriatal projections to the caudate nucleus in the cat with multiple retrograde tracers. Neuroscience 72:485-503.
58. Iacopino AM, Christakos S. 1990. Specific reduction of calcium-binding protein (28-kilodalton calbindin-D. gene expression in aging and neurodegenerative diseases. Proc Natl Acad Sci USA 87:4078-4082.
59. 28K-containing neurons in animal models of neurodegeneration: possible protection from excitotoxicity. Brain Res Mol Brain Res 13:251-261.
60. Issacs KR, Jacobowitz DM. 1994. Mapping of the colocalization of calretinin and tyrosine hydroxylase in the rat substantia nigra and ventral tegmental area. Exp Brain Res 99:34-42.
61. Issacs KR, Wolpoe ME, Jacobowitz DM. 1997. Calretinin-immunoreactive dopaminergic neurons from embryonic rat mesencephalon are resistant to levodopa-induced neurotoxicity. Exp Neurol 146:25-32.
62. Jiménez-Castellanos J, Graybiel AM. 1987. Subdivisions of the dopamine-containing A8-A9-A10 complex identified by their differential mesos-triatal innervation of striosomes and extrastriosomal matrix. Neuroscience 23:223-242.
63. Jiménez-Castellanos J, Graybiel AM. 1989. Evidence that histochemically distinct zones of the primate substantia nigra pars compacta are related to patterned distributions of nigrostriatal projection neurons and striatonigral fibers. Exp Brain Res 74:227-238.
64. Kadowaki K, Kishimoto J, Leng G, Emson PC. 1994. Up-regulation of nitric oxide synthase (NOS) gene expression together with NOS activity in the rat hypothalamo-hypophysial system after chronic salt loading: evidence of a neuromodulatory role of nitric oxide in arginine, vasopressin and oxytocin secretion. Endocrinology 134:1011-1017.
65. Karmy G, Carr PA, Yamamoto T, Chan SH, Nagy JI. 1991. Cytochrome oxidase immunohistochemistry in rat brain and dorsal root ganglia: visualization of enzyme in neuronal perikarya and in parvalbumin-positive neurons. Neuroscience 40:825-839.
66. Kaufman DL, Houser CR, Tobin AJ. 1991. Two forms of the γ-aminobutyric acid synthetic enzyme glutamate decarboxylase have distinct intraneuronal distributions and cofactors interactions. J Neurochem 56:720-723.
67. Kawaguchi Y, Katsumaru H, Kosaka T, Heizmann CW, Hama K. 1987. Fast spiking cells in rat hippocampus (CA1 region) contain the calcium-binding protein parvalbumin. Brain Res 416: 369-374
68. Kemp JM. 1970. The termination of strio-pallidal and strio-nigral fibers. Brain Res 17:125-128.
69. Kerwin JF, Lancaster JR, Feldman PL. 1995. Nitric oxide: a new paradigm for second messengers. J Med Chem 38:4343-4362.
70. Kitano H, Tanibuchi I. Jinnai K. 1998. The distribution of neurons in the substantia nigra pars reticulata with input from the motor, premotor and prefrontal areas of the cerebral cortex in monkeys. Brain Res 784:228-238.
71. Lei SZ, Pan Z-H, Aggarwal SK, Chen H-S V, Hartman J, Sucher NJ, Lipton SA. 1992. Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex. Neuron 8:1087-1099.
72. 28k and calretinin. Neuroscience 75:523-533.
73. Liu X-H, Kato H, Araki T, Itomaya Y, Kato K, Kogure K. 1994. An immunohistochemical observation of manganese superoxide dismutase in the rat substantia nigra after occlusion of the middle cerebral artery. Neurosci Lett 173:193-106.
74. Lindvall O, Björklund A. 1983. Dopamine- and norepinephrine-containing neuron systems: their anatomy in the rat brain. In: Emson PC, editor. Chemical neuroanatomy. New York: Raven Press, p 229-256.
75. Loiacono RE, Beart PM. 1992. Hippocampal lesions induced by microin-jection of the nitric oxide donor nitroprusside. Eur J Pharmacol 216: 331-333.
76. Marín O, González A , Smeets WJAJ. 1997a. Basal ganglia organization in amphibians: afferent connections to the striatum and the nucleus accumbens. J Comp Neurol 378:16-49.
77. Marín O, González A, Smeets WJAJ. 1997b. Anatomical substrate of amphibian basal ganglia involvement in visuomotor behaviour. Eur J Neurosci 9:2100-2109
78. Marín O, Smeets WJAJ, González A. 1998. Evolution of the basal ganglia in tetrapods: a new perspective based on recent studies in amphibians. Trends Neurosci 21:487-494.
79. Martin DL, Rimvall K. 1993. Regulation of γ-aminobutyric acid synthesis in the brain. J Neurochem 60:395-407.
80. Martínez-Murillo R, Villalba R, Montero-Caballero MI, Rodrigo J. 1989. Cholinergic somata and terminals in the rat substantia nigra: an immunocytochemical study with optical and electron microscopic techniques. J Comp Neurol 28:397-415.
81. 28k-containing neurons are restricted to the medial substantia nigra in humans. Neuroscience 65:8 7-91.
82. McRitchie DA, Hardman CD, Halliday GM. 1996. Cytoarchitectural distribution of calcium binding proteins in midbrain dopaminergic regions of rats and humans. J Comp Neurol 364: 121-150.
83. Mizutani A, Saito H, Abe K. 1993. Involvement of nitric oxide in long-term potentiation in the dentate gyrus in vivo. Brain Res 605:309-311.
84. Moncada S, Palmer RMJ, Higgs EA. 1991. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 43:109-142.
85. Montague PR, Gancayco CD, Winn MJ, Marchase RB, Friedlander MJ. 1994. Role of NO production in NMDA receptor-mediated neurotransmitter release in cerebral cortex. Science 263:973-977.
86. Moriizumi T, Leduc-Cross B, Wu J-Y, Hattori T. 1992. Separate neuronal populations of the rat substantia nigra pars lateralis with distinct projection sites and transmitter phenotypes. Neuroscience 43:711-720.
87. Moretto M, Lopez FJ, Negro-Vilar A. 1993. Nitric oxide regulates luteinizing hormone-releasing hormone secretion. Endocrinology 133:2399-2402.
88. Morris R, Southam E, Braid DJ, Garthwaite J. 1992. Nitric oxide may act as a messenger between dorsal root ganglion neurons and their satellite cells. Neurosci Lett 137:29-32.
89. Mugnaini E, Oertel WH. 1985. An atlas of the distribution of GABAergic neurons and terminals in the rat CNS as revealed by GAD immunocytochemistry. In: Björklund A, Hökfelt T, editors. Handbook of chemical neuroanatomy. Amsterdam: Elsevier. p 436-595.
90. Nagai T, McGeer PL, McGeer EG. 1983. Distribution of GABA-T intensive neurons in the rat forebrain and midbrain. J Comp Neurol 218:220-238.
91. Nelson EL, Liang C-L, Sinton CM, German DC. 1996. Midbrain dopaminergic neurons in the mouse: computer-assisted mapping. J Comp Neurol 369:361-371.
92. O'Dell TJ, Hawkins RD, Kandel ER, Arancio O. 1991. Tests on the roles of two diffusible substances in LTP: evidence for nitric oxide as a possible early retrograde messenger. Proc Natl Acad Sci USA 88:11285-11289.
93. Ottersen OP, Storm-Mathisen J. 1984. Glutamate- and GABA-containing neurons in the mouse and rat brain, as demonstrated with a new immunocytochemical technique. J Comp Neurol 229:374-392.
94. Overton PG Richards CD, Berry MS, Clark D. 1999. Long-term potentiation at excitatory amino acid synapses on midbrain dopamine neurons. NeuroReport 10:221-226.
95. Parent A, Hazrati L-N. 1995. Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res Rev 20:91-127.
96. Paxinos G, Watson C. 1998. The rat brain in stereotaxic coordinates. Orlando:Academic Press
97. Pérez de Mora M, Hernández-Gómez AM, Méndez-Franco J, Fuxe K. 1993. Cholecystokinin-8 increases (K+)-evoked [3H] gamma-aminobutyric acid release in slices from various brain areas. Eur J Pharmacol 250: 423-430.
98. Przedborski S.1996. Role of nitric oxide in MPTP-induced dopaminergic neurotoxicity. Proc Natl Acad Sci USA 93:4565-4571.
99. Puelles L, Verney C. 1998. Early neuromeric distribution of tyrosinehydroxylase-immunoreactive neurons in human embryos. J Comp Neurol 394:283-308.
100. Rajakumar N, Elisevich K, Flumerfelt BA. 1994. Parvalbumin-containing GABAergic neurons in the basal ganglia output system of the rat. J Comp Neurol 350:324-336.
101. Redgrave P, Marrow L, Dean P. 1992. Topographical organization of the nigrotectal projection in rat: evidence for segregated channels. Neuroscience 50:571-595.
102. Reiner A, Anderson KD. 1993. Co-occurrence of gamma-aminobutyric acid, parvalbumin and the neurotensin-related neuropeptide LANT6 in pallidal, nigral and striatal neurons in pigeons and monkeys. Brain Res 624:317-325.
103. Ribak CE, Vaughn JE, Roberts E. 1980. GABAergic nerve terminals decrease in the substantia nigra following hemitransections of the striatonigral and pallidonigral pathways. Brain Res 192: 413-420.
104. Rodrigo J, Springall DR, Uttenthal O, Bentura ML, Abadia-Molina F, Riveros-Moreno R, Martinez-Murillo R, Polak JM, Moncada S. 1994. Localization of nitric oxide synthase in the adult rat brain. Phil Trans R Soc Lond B 345:175-221.
105. Rodriguez M, González-Hernández T. 1999. Electrophysiological and morphological evidence for a GABAergic nigrostriatal pathway. J Neurosci 19:4682-4694
106. Rogers JH. 1992. Immunohistochemical markers in rat brain: colocalization of calretinin and calbindin-D28k with tyrosine hydroxylase. Brain Res 587:203-210.
107. 28k in rat brain: patterns of partial co-localization. Neuroscience 51:843-865.
108. Russchen FT, Jonker A. 1998. Efferent connections of the striatum and the nucleus accumbens in the lizard Gekko gecko. J Comp Neurol 276:61-80.
109. Scarnati E, Pacitti C. 1982. Neuronal responses to iontophoretically applied dopamine, glutamate, and GABA on identified dopaminergic cells in the rat substantia nigra after kainic acid-induced destruction of the striatum. Exp Brain Res 46:377-382.
110. Schiffman SN, Vanderhaeghen J-J. 1991. Distribution of cells containing mRNA encoding cholecystokinin in the rat central nervous system. J Comp Neurol 304:219-233.
111. Schmidt HH W, Walter U. 1994. NO at work. Cell 78:919-925.
112. Schneider JS, Yuwiler A, Markham CH. 1987. Selective loss of subpopulations of ventral mesencephalic dopaminergic neurons in the monkey following exposure to MPTP. Brain Res 411:144-150.
113. Schottler F, Collins JL, Fergus A, Okonkwo D, Kassell NF, Lee KS. 1996. Structural interactions between NOS-positive neurons and blood vessels in the hippocampus. NeuroReport 7:966-968.
114. Schulz JB, Matthews JB, Muqit MMK, Browne SE, Beal MF. 1995. Inhibition of neuronal nitric oxide synthase by 7-nitroidazole protects against MPTP-induced neurotoxicity in mice. J Neurochem 64:936-939.
115. Schuman EM. 1995. Nitric oxide signalling, long-term potentiation and long-term depression. In: Vincent SR, editor. Nitric oxide in the nervous system. London: Academic Press, p 125-150.
116. Schuman EM, Madison DV. 1991. A requirement for the intercellular messenger nitric oxide in long-term potentiation. Science 254:1503-1506.
117. Schuman EM, Madison DV. 1994. Nitric oxide and synaptic function. Annu Rev Neurosci 17: 153-183.
118. Schwyn RC, Fox CA. 1974. The primate substantia nigra: a Golgi and electron microscopic study. J Hirnforsch 16:95-126.
119. Seroogy KB, Fallon JH. 1989. Forebrain projections from cholecystokinin like-immunoreactive neurons in the rat midbrain. J Comp Neurol 279:415-435.
120. Seroogy KB, Dangaran K, Lim S, Haycock JW, Fallon JH. 1989a. Ventral mesencephalic neurons containing both cholecystokinin- and tyrosine hydroxylase-like immunoreactivities project to forebrain regions. J Comp Neurol 279:397-414.
121. Seroogy K, Schalling M, Brené S, Dagerling A, Chai SY, Hökfelt T, Persson, Brownstein HM, Huan R, Dixon J, Filer D, Schlessinger D, Goldstein M. 1989b. Cholecystokinin and tyrosine hydroxylase messenger RNAs in neurons of rat mesencephalon: peptide/ monoamine coexistence studies using in situ hybridization combined with immunocyto-chemistry. Exp Brain Res 74:149-162.
122. Shi W-X, Smith PL, Pun C-L, Millet B, Bunney BS. 1997. D1-D2 interaction in feedback control of midbrain dopamine neurons. J Neurosci 17:7988-7994.
123. Smeets, WJAJ. 1991. Comparative aspects of the distribution of substance P and dopamine immunoreactivity in the substantia nigra of amniotes. Brain Behav Evol 37:179-188.
124. Smith Y, Parent A, Seguela P, Descarries L. 1987. Distribution of GABA-immunoreactive neurons in the basal ganglia of the squirrel monkey (Saimiri sciureus). J Comp Neurol 259:50-64.
125. Szabo J. 1980. Organization of the ascending striatal afferents in monkeys. J Comp Neurol 189: 307-321.
126. Vidwans AS Kim S, Coffin DO, Wink DA, Hewett SJ. 1999. Analysis of the neuroprotective effects of various nitric oxide donor compounds in murine mixed cortical cell culture. J Neurochem 72:1843-1852.
127. Wu T, Wang HL. 1994. CCK-8 excites substantia nigra dopaminergic neurons by increasing a cationic conductance. Neurosci Lett 170:229-232.
128. 28K. Brain Res 526:303-307.
129. Yamamoto S, Golanov EV, Berger SB, Reis DJ. 1992. Inhibition of nitric oxide synthesis increases focal ischemic infarction in rat. J Cereb Blood Flow Metab 12:717-726.
130. Yelnik J, François C, Percheron G, Heyner S. 1987. Golgi study of the primate substantia nigra. I. Quantitative morphology and typology of nigral neurons. J Comp Neurol 265:455-472.
131. You ZB, Pettersson E, Herrera-Marschitz M, Hökfeld T, Terenius L, Nylander I, Goiny M, Hughes J, O'Connor WT, Ungerstedt U. 1994. Modulation of striatal aspartate and dynorphin B release by cholecystokinin (CCK-8) studied in vivo with microdialysis. NeuroReport 5:2301-2304.
132. You ZB, Herrera-Marschitz M, Pettersson E, Nylander I, Goiny M, Shou HZ, Kehr J, Godukhin O, Hökfeld T, Terenius L, Ungerstedt U. 1996. Modulation of neurotransmitter release by cholecystokinin in the neostriatum and substantia nigra of the rat: regional and receptor specificity. Neuroscience 74:793-804.
133. Yung KK, Bolam P J, Smith AD, Hersch SM, Ciliax BJ, Levey AI. 1995. Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: light and electron microscopy. Neuroscience 65:709-730.
134. Zhang F, Iadecola C. 1994. Reduction of focal ischemic damage by delayed treatment with nitric oxide donors. J Cereb Blood Flow Metab 14:574-580.